"Every year there are between 300 and 500 million cases of malaria, primarily in the developing world, making it a global priority that currently is not being met. This is an international partnership between China and the United States, working on an international goal. Biologists and medicinal chemists from both of our organizations will work together," Tortorella said.
Considered a disease of poverty, malaria is spread by mosquitoes in tropical and subtropical regions.
"Diseases of poverty that are prevalent in the developing world have enormous health and socio-economic consequences," Ruminski said.
"What we're doing here - trying to find safe, effective and affordable new drugs - fits into the mission of Saint Louis University. We're helping those who are under-served. We want to make sure that everyone, regardless of whether they are rich or poor, has access to the newest drugs."
Tortorella looks forward to what could come from the collaboration with former colleagues.
"We started together and it's come full circle. We're now working together again, this time as part of an international partnership between China and the United States, working on an international goal. We're taking advantage of each other's expertise as we work together," Tortorella said. "I see us as pioneers."
Raymond Tait, Ph.D., vice president for research at Saint Louis University, echoed the pioneering sentiment.
"We have believed from the outset that the Center would forge innovative relationships as our scientists pursue new treatments for global diseases. I am delighted at the GIBH partnership and hope that it is the first of many such partnerships that the Center will form."
Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The s
|SOURCE Saint Louis University Medical Center|
Copyright©2010 PR Newswire.
All rights reserved